Business Wire

FPT-CORPORATION

1.3.2024 08:37:38 CET | Business Wire | Press release

Share
FPT Announces First Acquisition in Japan with Full Ownership of Next Advanced Communications (NAC)

FPT Corporation (FPT) has acquired the IT services company Next Advanced Communications NAC Co., Ltd. (NAC), making it FPT’s first merger & acquisition (M&A) deal in Japan. With NAC as FPT’s wholly-owned subsidiary, the company aims to double its customer base and service offerings, deepening its foothold in the Japanese market.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240229752610/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The strategic investment signing ceremony between NAC and FPT took place in Tokyo, Japan (Photo: Business Wire)

The strategic move aligns with FPT’s global expansion strategy and enables the Vietnamese firm to capitalize on NAC’s talent pool of nearly 300 experienced engineers and strong expertise centred on technology and business consulting, architecture design, system planning, design, development, and operation. With these additional resources, FPT aims to achieve one billion USD in revenue from the Japanese market by 2027 and have more than half of its employees in Japan as multinational employees.

With current challenges for digital transformation in Japan, including an ageing population, shortage of ICT human resources and complexity of existing systems, the acquisition of NAC reflects FPT’s commitment to accompanying Japanese businesses in digital transformation and green transformation. This also enables FPT to foster sustainable growth and competitiveness and expand its services to new industries and a wider range of customers.

"Like NAC, FPT strives to leverage technology to address a variety of customer issues, with the goal of creating a sustainable society for everyone. We aim to enhance the Japanese engineer talent pool and cooperate with local companies to help our clients maintain business continuity despite geopolitical challenges. Additionally, FPT prioritizes and fosters a multicultural work environment. I believe NAC and FPT employees will find greater success and happiness in our collaboration," said Do Van Khac, FPT Software Senior Executive Vice President and FPT Japan CEO.

Naoto Yamazaki, NAC Chairman, said: “Since we started NAC 13 years ago, we have achieved success as an independent company. Today, as we join the FPT family, I believe not only can we maintain our growth but also form a stronger synergy for the future. NAC and FPT will strive to accelerate our business more than ever and become a company that can contribute to society.”

Since 2014, FPT has completed multiple M&A deals in the US and Europe. In Japan, the firm recently formed a joint venture with Konica Minolta and made a strategic investment in LTS Inc. The acquisition of NAC, as FPT’s first M&A deal in Japan, highlights its focused, long-term commitment to this key market. This also generates momentum for the corporation’s future M&A activities.

FPT has nearly two decades of presence in the Japanese market with the operation of FPT Japan, one of the country’s largest foreign-invested tech firms in terms of human resources. With a workforce of 2,900 onsite employees, nearly 15,000 employees working from overseas, 16 local offices and innovation hubs, FPT Japan has provided services and solutions to over 450 clients worldwide. The company is also recognized for excellent employee benefits and workplace happiness, earning accolades such as Best Workplaces in Asia, Best Places To Work in Japan, and Best Places To Work for Women in Japan.

About FPT Corporation

FPT Corporation (FPT) is a globally leading technology and IT services provider headquartered in Vietnam. FPT operates in three core sectors: Technology, Telecommunications, and Education. During over three decades of development, FPT has constantly provided practical and effective products to millions of people and tens of thousands of business and non-business organizations worldwide, establishing Vietnam’s position on the global tech map. Keeping up with the latest market trends and emerging technologies, FPT has developed the Made-by-FPT ecosystem of services, products, solutions, and platforms, which enables sustainable growth for organizations and businesses and offers distinctive experiences to customers. In 2023, FPT recorded a total revenue of US$2.17 billion and 70,000+ employees. For more information, please visit https://fpt.com.vn/en.

About NAC Co., Ltd.

NAC Co., Ltd. was established on March 31, 2011. The company's main businesses are marketing, consulting support, system planning, and system design, development, operation, and maintenance. By providing these services, NAC aims to realize a sustainable future as a member of the FPT Group.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240229752610/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release

Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0

FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 10:11:00 CEST | Press release

Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize

Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 08:00:00 CEST | Press release

Employee-led recognition places Boomi among the UK's top medium-sized employers, with a flight risk of just 3% against a technology sector average of 42% Boomi achieves an average employee happiness score of 86%, rated Excellent across all six dimensions of WorkL's workplace framework Flight risk of just 3%, compared to a technology sector average of 42%, reflecting exceptional levels of employee loyalty Rated Excellent for Diversity and Inclusion and Confidence in Management Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.b

LTM Has Issued an Offer to Acquire Randstad’s Technology and Consulting Services Business in Europe and Australia to Scale Domain-Driven Solutions and AI Services22.5.2026 07:09:00 CEST | Press release

The deal would be part of a 360° partnership with Randstad involving: Proposed acquisition of USD 500M+ (€469M) business, primarily across Aerospace & Defence, Automotive, Utilities and BFS Five-year IT services partnership to drive AI-enabled transformation for Randstad’s India Global Capability Center Strategic talent MSP to support LTM’s expanding global workforce LTM and Randstad announced that LTM has issued an offer to acquire Randstad’s Technology and Consulting Servicesbusiness in France, Germany, Belgium, Luxembourg and Australia, representing USD 500+ million (€469M) in annual revenue, to scale domain-driven solutions and AI services in the region. The proposed acquisition would expand LTM’s presence in key markets, primarily across Aerospace & Defence, Automotive, Utilities and BFS. It would enable local domain expertise and complementary regional capabilities in domain-driven digital engineering, cybersecurity and IoT, supported by onshore and nearshore delivery through cen

Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases22.5.2026 07:00:00 CEST | Press release

Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will obtain exclusive rights to commercialize a biosimilar for autoimmune diseases across Latin America (LATAM), excluding Brazil. Polpharma Biologics will retain full responsibility for the development and manufacturing of the biosimilar. Tuteur will be responsible for commercialization, marketing, and distribution in the licensed territories. This collaboration reflects a shared commitment to expanding patient access to high-quality, affordable biological therapies across the region. “Partnering with Tuteur represents an important step in advancing our mission to broaden access to biosimilars globally,” said Anjan Selz, CEO of Polpharma Biologics. “With their strong regional expertise and commercial capabilities in LATAM, we are well

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye